Company intelligence / Profile preview

MNG Laboratories

Atlanta, Georgia, United States

Ownership: Private
Employees: ~21
Development stage: Other

Overview

MNG Laboratories, now part of LabCorp, is a leading clinical diagnostic provider specializing in neurogenetic testing and complex biochemical testing for rare and inherited neurological, metabolic, and genetic conditions; it offers comprehensive testing menus (including whole genome/exome sequencing, mitochondrial DNA sequencing, and advanced neurochemistry assays) supporting clinical diagnosis and research.

Therapeutic areas: CardiovascularNeurologyEndocrinologyRare Diseases
Modalities: Next-Generation SequencingSanger SequencingCapillary ElectrophoresisMLPA® (Multiplex Ligation-dependent Probe Amplification)Neurochemistry testing
Industry: Molecular Diagnostics

Partnerships

LabCorp (parent company)Covance Drug Development (LabCorp division leveraging MNG’s testing for clinical research)

Beyond the preview

Go deeper on MNG Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MNG Laboratories.

Explore the full profile